This study investigates how to improve understanding of the sensory qualities of patients who have pain caused by cancer therapy. This information will add to the understanding of the mechanisms of this pain and may ultimately lead to better pain management.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT00515060.
Locations matching your search criteria
United States
Texas
Houston
M D Anderson Cancer CenterStatus: Active
Contact: Patrick M. Dougherty
Phone: 713-745-0438
PRIMARY OBJECTIVE:
I. To examine the feasibility of using quantitative sensory testing procedures, widely applied to the experimental study of sensory processing in humans both with and without various pain syndromes, to now characterize the psychophysical properties of neuropathic pain that has developed as a consequence of cancer therapy.
OUTLINE: This is an observational study.
Patients undergo quantitative sensory testing over about 1 hour on 3 sites within the area affected by pain and 1 site outside the area affected by pain. Patients undergoing chemotherapy undergo these tests before each round of treatment, and patients enrolled in a collaborative study that also uses quantitative sensory testing follow timepoints in that study. Patients who complete chemotherapy also undergo a skin punch biopsy of the affected area.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationM D Anderson Cancer Center
Principal InvestigatorPatrick M. Dougherty
